The Fort Worth Press - Organto Announces Reinstatement of Trading on the TSX Venture Exchange

USD -
AED 3.672498
AFN 64.999762
ALL 82.324126
AMD 360.539884
ANG 1.790403
AOA 917.999837
ARS 1545.654536
AUD 1.475394
AWG 1.8
AZN 1.702091
BAM 1.769883
BBD 2.014669
BDT 124.715381
BGN 1.77347
BHD 0.378283
BIF 3011.021908
BMD 1
BND 1.291151
BOB 11.678099
BRL 5.666303
BSD 1.000231
BTN 94.44641
BWP 14.015512
BYN 3.004037
BYR 19600
BZD 2.016692
CAD 1.42684
CDF 2314.999833
CHF 0.839045
CLF 0.025469
CLP 1002.376741
CNY 6.67175
CNH 6.67242
COP 3319.97
CRC 449.312832
CUC 1
CUP 24.064952
CVE 100.150155
CZK 22.133023
DJF 178.554905
DKK 6.779349
DOP 60.996961
DZD 137.215041
EGP 53.485567
ERN 15
ETB 164.576405
EUR 0.90689
FJD 2.27435
FKP 0.756889
GBP 0.756535
GEL 2.590271
GGP 0.756889
GHS 11.725036
GIP 0.756889
GMD 73.999527
GNF 8883.748356
GTQ 7.646644
GYD 209.264655
HKD 7.845275
HNL 26.963306
HRK 6.831965
HTG 131.491813
HUF 330.604024
IDR 18235.4
ILS 3.216698
IMP 0.756889
INR 94.2455
IQD 1520.116116
IRR 1913737.503992
ISK 123.929969
JEP 0.756889
JMD 158.434254
JOD 0.708975
JPY 159.736964
KES 130.049711
KGS 87.4355
KHR 4079.999705
KMF 447.000026
KPW 900.00035
KRW 1335.485024
KWD 0.31147
KYD 0.835579
KZT 446.945163
LAK 22570.87132
LBP 89792.715562
LKR 333.505692
LRD 170.463102
LSL 16.951422
LTL 2.95274
LVL 0.60489
LYD 6.463464
MAD 9.936862
MDL 18.213816
MGA 4555.721867
MKD 55.830725
MMK 2100.274506
MNT 3605.662913
MOP 8.103688
MRU 40.552456
MUR 47.620147
MVR 15.385792
MWK 1738.739965
MXN 18.52569
MYR 4.086097
MZN 63.898478
NAD 16.951422
NGN 1343.570268
NIO 36.90298
NOK 9.562975
NPR 151.114437
NZD 1.80926
OMR 0.385095
PAB 1.000231
PEN 3.411802
PGK 4.575679
PHP 63.960057
PKR 277.274459
PLN 3.994725
PYG 6207.891986
QAR 3.64425
RON 4.851899
RSD 106.55897
RUB 82.809516
RWF 1483.467138
SAR 3.82571
SBD 8.097697
SCR 13.874904
SDG 601.541949
SEK 10.070015
SGD 1.287865
SHP 0.752984
SLE 23.049834
SLL 20969.503664
SOS 573.048487
SRD 37.489734
STD 20697.981008
STN 22.225246
SVC 8.773983
SYP 13002.000337
SZL 16.946523
THB 33.874991
TJS 9.249966
TMT 3.5
TND 3.008501
TOP 2.40776
TRY 50.374755
TTD 6.806368
TWD 32.891399
TZS 2655.145825
UAH 45.588969
UGX 4131.053487
UYU 40.541335
UZS 12057.876355
VES 912.87925
VND 25725.5
VUV 120.320092
WST 2.810586
XAF 594.881002
XAG 0.02044
XAU 0.0002568624
XCD 2.70255
XCG 1.807139
XDR 0.707052
XOF 594.881002
XPF 108.325017
YER 236.549828
ZAR 16.93433
ZMK 9001.197903
ZMW 20.500748
ZWL 321.999592
SSP 5945.381189
MXV 2.080458
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Organto Announces Reinstatement of Trading on the TSX Venture Exchange
Organto Announces Reinstatement of Trading on the TSX Venture Exchange

Organto Announces Reinstatement of Trading on the TSX Venture Exchange

TORONTO, ON and BREDA, NETHERLANDS / ACCESS Newswire / March 7, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTC PINK:OGOFF) ("Organto" or the "Company"), a leading provider of organic and non-GMO fruit and vegetable products, is pleased to announce that the TSX Venture Exchange (the "TSXV" or the "Exchange") has accepted its application for reinstatement of trading of the Company's common shares on the TSXV. This follows the successful resolution of the Failure-to-File Cease Trade Order (the "FFCTO") issued by the British Columbia Securities Commission (the "BCSC") on July 16, 2024, and revoked on January 2, 2025. The Company expects its common shares to be reinstated for trading shortly.

Text size:

The FFCTO was issued as a result of the delay in the filing of the Company's annual audited financial statements for the year ended December 31, 2023. The delay in filing the annual financial statements, which was a result of changes in Company personnel and reporting systems in late 2023 and early 2024, had a cascading effect which caused the Company to also be late in filing its interim financial statements for both the three-month period ended March 31, 2024, and the six-month period ended June 30, 2024 (the audited and interim financial statements collectively the "Late Financial Statements"). The Company filed the Late Financial Statements in October and November 2024, at which time the Company applied to the BCSC to have the FFCTO revoked. Upon the revocation of the FFCTO, the Company applied to the TSXV to have its common shares reinstated for trading. The Company also filed its financial statements for the nine-month period ended September 30, 2024 in November 2024 in accordance with regulatory requirements.

Over the course of 2024 and into 2025, the Company has restructured and repositioned its operations including streamlining its product portfolio, shifting its marketing strategy and re-engineering its operating platform to improve processes and reduce costs. In June 2024, the Company sold three European operating subsidiaries, further streamlining operations, reducing operating costs and improving its balance sheet. The Company also continues to focus on improving its balance sheet to provide greater operating flexibility. The Company remains focused on leveraging the positive changes that have been made to date and remains committed to building a world-class foods company serving growing global healthy foods markets, with the goal of building long-term shareholder value.

The Company acknowledges and appreciates the patience of its shareholders and stakeholders during this process and reaffirms its commitment to adhering to high standards of compliance and corporate governance.

In addition to the announcement regarding the reinstatement of trading on the TSXV, the Company is providing an update on a number of matters, including the following:

Working Capital Deficiency

The Company's September 30, 2024, interim financial statements reflect a working capital deficiency of $14,478,925. The largest components of this deficiency are convertible debentures of $10,641,350 and associated accrued interest of $1,621,531, as well as short-term loans of $1,626,241 and associated accrued interest of $82,860. Following the reinstatement of the Company's common shares for trading, the Company plans to seek Exchange acceptance to restructure its convertible debt and associated accrued interest obligations, settle existing debts via the issuance of shares, and complete a private placement of common shares. Upon completion of these actions, the Company expects to realize improved cash flow from operations and a return to positive working capital in the near term. There can be no assurance that the Company will be successful in completing the proposed debt settlement and private placement however management has been discussing same with certain creditors and potential investors and is fairly confident that there will be take up of same.

Related Party Loans

During 2023, the Company received advances from two related parties. These advances were unsecured and expected to be of a very short duration. Steve Bromley ("Bromley"), the Company's CEO, advanced USD$ 325,000, and Bob Kouw ("Kouw"), the Company's COO advanced CDN$ 33,000. An additional USD $30,000 was received from Bromley in the first quarter of 2024. The Bromley advances were applied as part of the funds in the April 2024 private placement (see April 16, 2024 news release) and the Kouw advance remains outstanding. Further details can be found in the Company's December 31, 2023 and subsequent financial statements.

Small Cap Invest Agreement

To assist with its corporate awareness and marketing program in Europe, the Company engaged Small Cap Invest GmbH ("Small Cap"), an arm's length Frankfurt, Germany based firm, to provide introductions to Small Cap's network of media representatives and qualified and institutional investors, organizing non-deal roadshows and city events, and advising the Company on communications strategies. The agreement was for one-year term that commenced on November 1, 2023 and ended on October 31, 2024. Small Cap received a total fee of $80,000 as an annual retainer. To the best of the Company's knowledge, neither Small Cap nor its managing director, Alexander Friedrich, held any interest in the Company at the time Small Cap was engaged. The Company has completed and filed a TSXV Form 3C - Declaration of Certified Filing - Promotional Investor Relations and Market-Making Activities with the TSXV.

Update Regarding March 2024 8% Convertible Debentures Announcement

On March 12, 2024, the Company announced that it had reached an agreement with the holders of 68.1% of its 5 year, 8% convertible unsecured subordinated debentures, due November 30, 2026, with an aggregate face value of $8,050,000 (the "Debentures"), to a proposal to restructure these Debentures, converting 50% to equity, extending the maturity date and amending conversion terms (the "Amendments"). The Amendments are subject to TSXV acceptance and execution of a supplemental indenture. Given material changes in the Company's business, the FFCTO and suspension of trading, the Amendments were not completed, and the Company is in the process of negotiating amended terms and will apply for approval once the new terms have been finalized.

November 2023 Private Placement Update

On November 14, 2023, the Company announced plans for a private placement financing of up to CDN $2.0 million, and in December 2023 provided a further update on the status of this financing. Organizational issues as the Company dealt with business restructuring and the sale of three of its subsidiaries prevented this planned financing from being completed until April 2024 when it ultimately closed for total proceeds of CDN $575,000 (see April 16, 2024 news release). CDN $515,000 of the total proceeds from this financing were applied as repayments of related party loans, accrued interest and unpaid expenses.

Disclosure of Loans Received in Advance of Planned Private Placements

The Company's recent financial statements include the classification of funds received as short-terms loans in advance of a planned private placement. The Company wishes to clarify that any future settlements of these loans will be treated as shares-for-debt transactions under Exchange Policy 4.3, and not as part of a private placement under Exchange Policy 4.1.

ON BEHALF OF THE COMPANY

Steve Bromley
Chair and CEO

For more information contact:

Officer Responsible for the Press Release
Steve Bromley, Chair and Chief Executive Officer
647-228-8883
[email protected]

Investor Relations
John Rathwell, Senior Vice President, Investor Relations & Corporate Development
647 629 0018
[email protected]

ABOUT ORGANTO

Organto is an integrated provider of branded, private label, and distributed organic and non-GMO fruit and vegetable products using a strategic asset-lighter business model to serve a growing socially responsible and health-conscious consumer around the globe. Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people, and its shareholders.

FORWARD LOOKING STATEMENTS

This news release may include certain forward-looking information and statements, as defined by law including without limitation Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting the timing of reinstatement of the Company's common shares for trading on the TSXV and the impact of ongoing changes in the business that have been implemented throughout 2024 and into 2025 with the goal of restructuring and repositioning operations focused on building a world class foods company; plans to improve the Company's working capital deficit via improved cash from operations, restructuring of convertible debt obligations, shares for debt settlements and future private placements; and plans to renegotiate terms and restructure outstanding convertible debentures. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including without limitation, the assumption that no unforeseen circumstances will arise that would cause the Company's common shares not to be reinstated for trading on the TSXV as expected and the changes that have been implemented in the business will have the desired outcome. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. For further information on these and other risks and uncertainties that may affect the Company's business, see the "Risks and Uncertainties" and "Forward-Looking Statements" sections of the Company's annual and interim management's discussion and analysis filings with the Canadian securities regulators, which are available under the Company's profile at www.sedarplus.ca. Except as required by law, Organto does not assume any obligation to release publicly any revisions to forward-looking statements contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE: Organto Foods, Inc.



View the original press release on ACCESS Newswire

L.Coleman--TFWP